LFST Stock Recent News
LFST LATEST HEADLINES
LifeStance Health Group (LFST) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.13 per share a year ago.
SCOTTSDALE, Ariz., Aug. 08, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the second quarter ended June 30, 2024.
NEW YORK, NY / ACCESSWIRE / August 6, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of LifeStance Health Group, Inc. ("LifeStance") (NASDAQ:LFST) concerning possible violations of federal securities laws. LifeStance is the subject of a report published by Hindenburg Research on February 1, 2024, titled: "LifeStance: A Private Equity-Backed Mental Health Rollup Headed For A Breakdown.
NEW YORK, NY / ACCESSWIRE / August 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of LifeStance Health Group, Inc. ("LifeStance") (NASDAQ:LFST) concerning possible violations of federal securities laws. LifeStance is the subject of a report published by Hindenburg Research on February 1, 2024, titled: "LifeStance: A Private Equity-Backed Mental Health Rollup Headed For A Breakdown.
NEW YORK, NY / ACCESSWIRE / August 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of LifeStance Health Group, Inc. ("LifeStance") (NASDAQ:LFST) concerning possible violations of federal securities laws. LifeStance is the subject of a report published by Hindenburg Research on February 1, 2024, titled: "LifeStance: A Private Equity-Backed Mental Health Rollup Headed For A Breakdown.
LifeStance Health (LFST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NEW YORK, NY / ACCESSWIRE / August 1, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of LifeStance Health Group, Inc. ("LifeStance") (NASDAQ:LFST) concerning possible violations of federal securities laws. LifeStance is the subject of a report published by Hindenburg Research on February 1, 2024, titled: "LifeStance: A Private Equity-Backed Mental Health Rollup Headed For A Breakdown.
NEW YORK, NY / ACCESSWIRE / July 30, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of LifeStance Health Group, Inc. ("LifeStance") (NASDAQ:LFST) concerning possible violations of federal securities laws. LifeStance is the subject of a report published by Hindenburg Research on February 1, 2024, titled: "LifeStance: A Private Equity-Backed Mental Health Rollup Headed For A Breakdown.
The mean of analysts' price targets for LifeStance Health (LFST) points to a 54.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
LOS ANGELES, CA / ACCESSWIRE / July 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.